In response to a new study analyzing the risk of falls seen with newer antiandrogens for prostate cancer, Julie Graff, M.D., and Alexandra Sokolova, M.D., publish an editorial suggesting the risk-benefit ratio of adding a second-generation AA to treatment may be different for a patient who wants to stay alert and sharp to keep a complex job "versus someone whose primary goal is to see their young children graduate high school.”

A nonhuman primate study led by Jonah Sacha, Ph.D., finds transplanted stem cells help kill HIV-infected cells by recognizing them as foreign invaders, much like they do for certain types of cancer; Sacha says: "As with all things in science, it’s going to be a long and winding road. But now that we understand the mechanisms of this, it sort of points us in a new direction, which is the cure is this way, and this is the road you have to walk."

Scripps News covers efforts underway to reduce harm and increase addiction treatment, including an interview with Bradley Buchheit, M.D., medical director of OHSU’s Harm Reduction and Bridges to Care clinic. He says, “Until those treatment services are easier to access than street drugs, it’s going to be really hard for us to get ourselves out of the current crisis that we’re in.”

Vijayshree Yadav, M.D., M.C.R., discusses the impact of a low-fat diet on quality of life and symptom management in a video interview.

A story on the effectiveness of antiviral treatments in reducing patient mortality references research from Kristina Bajema, M.D.

Continued coverage of research led by Jonah Sacha, Ph.D., on how stem cell transplantation can kill the virus that causes AIDS.

An Oregonian story on Providence nurses authorizing a strike mentions the nurse's union is in negotiations with OHSU.

An Oregon Capital Chronicle story on the national Adderall shortage references comments from a The New York Times interview with Ximena Levander, M.D., who noted telemedicine prescriptions were reaching patients whose medical conditions would otherwise go untreated.

A profile on Brian Druker, M.D., and his work to develop the drug Gleevec for patients with chronic myeloid leukemia.

In an Inverse story on the potential FDA approval of an over-the-counter birth control pill, Alison Edelman, M.D., says it’s a grassroots effort that’s been years, if not decades, in the making.